Overview

Overview

Proud to be part of the Glickman Urological & Kidney Institute

Cleveland Clinic nephrologists are experts at evaluating and managing chronic kidney disease (CKD). An innovative team-care model addresses the life cycle of the disease. The Center for Chronic Kidney Disease focuses on empowering patients through education and tailors treatment to improve patients’ quality of life.

Experienced kidney failure specialists and other staff members engage patients in customized care programs that help them understand their condition and participate in their own care. Treatment is focused on slowing the progression of CKD, identifying and managing risks for developing cardiovascular disease, optimizing the transition to renal replacement such as dialysis or kidney transplant, and decreasing the risk of complications from surgery.

Additionally, the Center is dedicated to cutting-edge research regarding CKD’s relationship with other serious health problems, including cardiovascular disease, diabetes and anemia.

What We Treat

What We Treat

Georges Nakhoul, MD, discusses risks, symptoms, diagnosis and treatment options of chronic kidney disease (CKD)

Conditions & Treatments

Research and Innovations

Research and Innovations

CKD Registry

Cleveland Clinic developed a registry with over 93,000 patients affected by CKD that will aid in monitoring this population’s progress during the life cycle of the disease. The registry includes demographic information, critical parameters, and outcome measurements.

The ability to follow patients from primary care management to nephrologic care on to CKD care and finally to renal replacement therapy, is a valuable foundation for future research and discovery. The registry helps to shed light on how the medical community recognizes and manages CKD.

CKD Carepath

The National Kidney Foundation set evidence-based clinical practice guidelines for all stages of CKD and related complications. Cleveland Clinic is developing a computer-based CKD Carepath to assist caregivers in the diagnosis and management of CKD. The CKD Carepath will inform physicians of CKD management suggestions based on the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative. Because CKD is often discovered in later stages, and sometimes a person has lost 70 percent of kidney function by that time, Cleveland Clinic is taking aggressive steps to identify the disease in its early stages. That way, CKD and related diseases, such as cardiovascular disease, can be managed with optimum results.

Chronic Renal Insufficiency Cohort (CRIC) Study

Cleveland Clinic is participating in a long-term observational study of 3,000 individuals with mild to moderate CKD. The study, funded by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), is examining the relationship between CKD and cardiovascular disease in order to better diagnose and treat both conditions.

Staff

Staff

Robert Heyka , MD
Department Chair, Nephrology & Hypertension
Georges Nakhoul , MD
Director, Center for Chronic Kidney Disease
Diana Deitzer , DO
Medical Director, Avon Hospital Nephrology and Dialysis Services
Jonathan Taliercio , DO
Medical Director, Cleveland Clinic West Dialysis Unit
George Thomas , MD
Director, Center for Blood Pressure Disorders
Leslie Wong , MD
Vice Chair, Clinical Transformation